Your browser doesn't support javascript.
loading
Stratification of phaco-trabectome surgery results using a glaucoma severity index in a retrospective analysis.
Roy, Pritha; Loewen, Ralitsa T; Dang, Yalong; Parikh, Hardik A; Bussel, Igor I; Loewen, Nils A.
Afiliação
  • Roy P; Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, 15213, PA, USA.
  • Loewen RT; Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, 15213, PA, USA.
  • Dang Y; Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, 15213, PA, USA.
  • Parikh HA; Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, 15213, PA, USA.
  • Bussel II; Institute of Ophthalmology and Visual Science, New Jersey Medical School, Newark, 07103, NJ, USA.
  • Loewen NA; Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, 15213, PA, USA. Igor.Bussel@gmail.com.
BMC Ophthalmol ; 17(1): 30, 2017 Mar 21.
Article em En | MEDLINE | ID: mdl-28327135
ABSTRACT

BACKGROUND:

To stratify the outcomes of phacoemulsification combined with trabectome surgery using a new glaucoma severity index.

METHODS:

This is a retrospective, observational cohort study that included open angle glaucoma patients with visually significant cataract that had phacoemulsification combined with trabectome surgery. Exclusion criteria were follow-up less than 12 months, any other surgeries or diagnosis of neovascular or active uveitic glaucoma. Patients were stratified into four groups according to the Glaucoma Index (GI) that incorporated preoperative intraocular pressure (IOP), number of medications and visual field status. The primary outcome measures were IOP reduction and the success rate at 12 months. We examined the relationship between GI group and IOP and medications at one year with a linear regression analysis and survival with log-rank testing.

RESULTS:

Of 1374 patients, a total of 498 cases with 12 month follow-up were included in the study after applying the exclusion criteria. At one year, IOP of GI groups 1 through 4 was reduced by 2.9 ± 4.4, 3.6 ± 5.0, 3.9 ± 5.3, and 9.2 ± 7.6 mmHg for. Individuals in the next higher GI group had a 1.69 ± 0.2 mmHg larger IOP decrease. The success rate was 98%, 93%, 96% and 88% at one year for GI groups 1 to 4 (p < 0.05).

CONCLUSIONS:

A substantial IOP reduction was seen in subjects with more advanced glaucoma suggesting that the trabecular meshwork is the primary impediment to outflow and its ablation benefits those eyes relatively more than in mild glaucoma. A larger IOP reduction can be expected in individuals with a higher GI group that indicates a clinically more challenging glaucoma.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Malha Trabecular / Catarata / Trabeculectomia / Glaucoma de Ângulo Aberto / Facoemulsificação / Pressão Intraocular Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Malha Trabecular / Catarata / Trabeculectomia / Glaucoma de Ângulo Aberto / Facoemulsificação / Pressão Intraocular Idioma: En Ano de publicação: 2017 Tipo de documento: Article